Skip to main content
Explore URMC

UMMY20033 /Steroid Sparing Treatment/ Frank Passero

Basic Study Information

The purpose of this study is to determine the effects of daratumumab and lenalidomide without steroids for treating patients with multiple myeloma.

Location: University of Rochester Medical Center

Lead Researcher (Principal Investigator)

Lead Researcher:  Frank Passero

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email:

Additional Study Details

Return to Search